Hostname: page-component-586b7cd67f-l7hp2 Total loading time: 0 Render date: 2024-11-24T22:53:26.533Z Has data issue: false hasContentIssue false
  • English
  • Français

Magnetite-PLGA Microparticles for Oral Delivery of Insulin

Published online by Cambridge University Press:  01 February 2011

Jianjun Cheng ,
Christopher H. Yim ,
Benjamin A. Teply ,
Dennis Ho ,
Omid C. Farokhzad  and
Robert S. Langer
Jianjun Cheng
Affiliation:
Department of Chemical Engineering
Christopher H. Yim
Affiliation:
Department of Chemical Engineering
Benjamin A. Teply
Affiliation:
Department of Chemical Engineering
Dennis Ho
Affiliation:
Department of Biology
Omid C. Farokhzad
Affiliation:
Division of Health Sciences and Technology, Massachusetts Institute of Technology, Cambridge, MA 02139 Department of Anesthesiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115
Robert S. Langer
Affiliation:
Department of Chemical Engineering
Get access

Abstract

Magnetic responsive particles were designed for use in oral delivery of insulin. Magnetite nanoparticles (12 nm average size) were synthesized and co-encapsulated with insulin into poly(lactide-co-glycolide) (PLGA) microparticles (4.6 ± 2.2 μm average particle size) through the double-emulsion method. The spherical structures of resulting microparticles were well maintained at magnetite content 5 wt % or less. Mice were gavaged with 125I-insulin-magnetitePLGA microparticles and a circumferential trans-abdominal magnetic field was applied forty minutes after administration to retard the transit of the microparticles in the intestinal tract. As control, mice were similarly dosed without the subsequent trans-abdominal magnetic field. Mice were sacrificed, and the intestinal radioactivity was 101% and 145% higher in treated mice versus the control at 6 h and 12 h, respectively. A single administration of 50 unit/kg Humulin Rmagnetite-PLGA microparticles to the fasted mice resulted in 66% reduction of blood glucose level in the presence of external magnetic field at 12 h, compared to 27% reduction in the absence of magnetic field.

Type
Research Article
Information
MRS Online Proceedings Library (OPL) , Volume 873: Symposium K – Biological and Bio-Inspired Materials and Devices , 2005 , K5.8
Copyright
Copyright © Materials Research Society 2005

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1 Goldberg, M. and Gomez-Orellana, I., Nature Reviews Drug Discovery 2, 289 (2003).Google Scholar
2 Fasano, A. and Uzzau, S., Journal of Clinical Investigation 99, 1158 (1997).Google Scholar
3 Uchiyama, T., Sugiyama, T., Quan, Y. S., Kotani, A., Okada, N., Fujita, T., Muranishi, S., and Yamamoto, A., Journal of Pharmacy and Pharmacology 51, 1241 (1999).Google Scholar
4 Yamamoto, A., Okagawa, T., Kotani, A., Uchiyama, T., Shimura, T., Tabata, S., Kondo, S., and Muranishi, S., Journal of Pharmacy and Pharmacology 49, 1057 (1997).Google Scholar
5 Lowman, A. M., Morishita, M., Kajita, M., Nagai, T., and Peppas, N. A., Journal of Pharmaceutical Sciences 88, 933 (1999).Google Scholar
6 Yamamoto, A., Taniguchi, T., Rikyuu, K., Tsuji, T., Fujita, T., Murakami, M., and Muranishi, S., Pharmaceutical Research 11, 1496 (1994).Google Scholar
7 Chen, H. M. and Langer, R., Pharmaceutical Research 14, 537 (1997).Google Scholar
8 Kisel, M. A., Kulik, L. N., Tsybovsky, I. S., Vlasov, A. P., Vorob'yov, M. S., Kholodova, E. A., and Zabarovskaya, Z. V., International Journal of Pharmaceutics 216, 105 (2001).Google Scholar
9 Iwanaga, K., Ono, S., Narioka, K., Kakemi, M., Morimoto, K., Yamashita, S., Namba, Y., and Oku, N., Journal of Pharmaceutical Sciences 88, 248 (1999).Google Scholar
10 Mathiowitz, E., Jacob, J. S., Jong, Y. S., Carino, G. P., Chickering, D. E., Chaturvedi, P., Santos, C. A., Vijayaraghavan, K., Montgomery, S., Bassett, M., and Morrell, C., Nature 386, 410 (1997).Google Scholar
11 Carino, G. P., Jacob, J. S., and Mathiowitz, E., Journal of Controlled Release 65, 261 (2000).Google Scholar
12 Lehr, C. M., Bouwstra, J. A., Kok, W., Deboer, A. G., Tukker, J. J., Verhoef, J. C., Breimer, D. D., and Junginger, H. E., Journal of Pharmacy and Pharmacology 44, 402 (1992).Google Scholar
13 Hafeli, U. O., International Journal of Pharmaceutics 277, 19 (2004).Google Scholar
14 Mehta, R., Upadhyay, R., Charles, S., and Ramchand, C., Biotechnology Techniques 11, 493 (1997).Google Scholar
15 Chen, H., Torchilin, V., and Langer, R., Journal of Controlled Release 42, 263 (1996).Google Scholar